4 research outputs found
Kaplan-Meier survival curves.
<p>Low MBDA scores (<30, green; n = 220), moderate MBDA scores (30–44, blue; n = 155), high MBDA scores (>40, red; n = 64) for three definitions of disease relapse. TNFi restart (top), medication escalation (middle) and physician-reported flare (bottom).</p
Disease relapse by three criteria at 12 months for patients classified by baseline MBDA score.
<p>Disease relapse by three criteria at 12 months for patients classified by baseline MBDA score.</p
Univariate and multivariate analyses of high (>44) versus moderate or low baseline MBDA score as a predictor of disease relapse at 12 months.
<p>Univariate and multivariate analyses of high (>44) versus moderate or low baseline MBDA score as a predictor of disease relapse at 12 months.</p
Baseline characteristics of POET patients grouped according to sample availability for MBDA testing.
<p>Baseline characteristics of POET patients grouped according to sample availability for MBDA testing.</p